Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04876456
Title A Phase II Trial Evaluating the Efficacy of Cabozantinib With Patients With Refractory GCTs
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nabil Adra
Indications

ovarian germ cell cancer

seminoma

germ cell cancer

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.